Pfizer’s boss thinks covid-19 is reshaping Big Pharma for the better
The industry is becoming nimbler and more innovative
“THE IMPOSSIBLE can many times become possible,” reflects Albert Bourla, boss of Pfizer. He is talking about the giant American drugmaker’s speedy development (with BioNTech of Germany) of a vaccine against covid-19. The sentiment also applies to the turnaround in the fortunes of the pharmaceutical industry.
This article appeared in the Business section of the print edition under the headline “Reformulated”
Business April 10th 2021
From the April 10th 2021 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Business
Corporate America’s diversity wars are just getting started
Donald Trump’s attacks on DEI are causing huge headaches for bosses
What Elon Musk should learn from Larry Ellison
The founder of Oracle has demonstrated remarkable staying power
Football clubs are making more money than ever. Players not so much
For both teams and their top stars, it helps to have a brand
The allure of the company town
Lego, Corning and the survival of an old idea
From cribs to carriers, high-end baby products are in vogue
Demographic and technological changes are making infancy more expensive
No one gains from American tariffs on cars from Mexico and Canada
Donald Trump’s levy will hit his country’s carmakers hardest